Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95-17
- 1 May 2006
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 65 (1) , 45-51
- https://doi.org/10.1016/j.ijrobp.2005.11.027
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Accelerated partial breast irradiation: A change in treatment paradigm for early stage breast cancerJournal of Surgical Oncology, 2003
- Limited-Field Radiation Therapy in the Management of Early-Stage Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Accelerated partial breast irradiation: an updated report from the American Brachytherapy SocietyBrachytherapy, 2002
- Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancerThe American Journal of Surgery, 2000
- Relation between appropriateness of primary therapy for earlystage breast carcinoma and increased use of breast-conserving surgeryThe Lancet, 2000
- Brachytherapy as the sole method of breast irradiation in tis, T1, T2, No-1 breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- The use of iodine-125 seeds as a substitute for iridium-192 seeds in temporary interstitial breast implantsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunkInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- The late effects of toxicity scoringInternational Journal of Radiation Oncology*Biology*Physics, 1988